Marksans Pharma Buyback FAQ's

The Marksans Pharma Buyback price is set at Rs 60 Per Share. The Marksans Pharma Buyback opens on July 15, 2022 and closes on January 14, 2023.

There is no concept of Tender form in case of an open market offer through the Stock exchange. Any equity shareholder holding the Equity shares of Marksans Pharma Buyback can participate in the buyback offer through their stockbroker.

The Public Announcement for Marksans Pharma Buyback can be download here.

Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.

The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.

Necessity of the Issue:

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

The Marksans Pharma Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one’s need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.